Since the tumor promoting effects in these immune cells were abolished upon inhibition of the enzyme phospholipase D, this indicates that this PLD from the immune cells, which functioned as part of an inflammatory response/process, also has a key role in breast cancer progression. Here, GPLD1 is linked to breast carcinoma.